Here’s why a Dublin pharma company will be listed on the Israeli stock exchange

Story excerpt provided by Columbus Business First.

Written by Carrie Ghose.

Navidea Biopharmaceuticals Inc. will be added to the Tel Aviv Stock Exchange in Israel when markets reopen Tuesday after Labor Day, extending its trading hours and exposing its often battered stock to overseas biotech investors.

Shares in Dublin-based Navidea (NYSEMKT:NAVB) have climbed on the NYSE MKT LLC small-cap exchange since it announced Aug. 24 it would seek approval for listing on the TASE. The stock as of Wednesday was flirting with its 52-week high after swinging between 97 cents and $2.02 over the past year.

Click here to read the complete article.

Originally published September 2, 2015.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: